Early life stress and inflammatory mechanisms of fatigue in the Coronary Artery Risk Development in Young Adults (CARDIA) study

Brain, Behavior, and Immunity

Volumn 26, Issue 6, 2012, Pages 859-865

  Cho, Hyong Jin ^a   Bower, Julienne E ^a,b   Kiefe, Catarina I ^c   Seeman, Teresa E ^d   Irwin, Michael R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C reactive protein; Early life stress; Fatigue; Interleukin 6; Mediation; Population based longitudinal study; Sickness behavior; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ADULTHOOD; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; BODY MASS; COMORBIDITY; CORONARY ARTERY DISEASE; CORRELATION COEFFICIENT; DEMOGRAPHY; EARLY LIFE STRESS; FATIGUE; FEMALE; HEALTH SURVEY; HUMAN; ILLNESS BEHAVIOR; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE; SLEEP DISORDER; SMOKING; STRESS; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; BEHAVIOR; C-REACTIVE PROTEIN; CHILD; COMORBIDITY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSION; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; PAIN; PHARMACEUTICAL PREPARATIONS; RISK; SLEEP DISORDERS; SMOKING; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84863876313     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.04.005     Document Type: Review

References (39)

1. Amato M.P., Ponziani G., Rossi F., Liedl C.L., Stefanile C., Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult. Scler. 2001, 7:340-344.
2. Anderson J.S., Ferrans C.E. The quality of life of persons with chronic fatigue syndrome. J. Nerv. Ment. Dis. 1997, 185:359-367.
3. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51:1173-1182.
4. Cho H.J., Seeman T.E., Bower J.E., Kiefe C.I., Irwin M.R. Prospective association between C-reactive protein and fatigue in the coronary artery risk development in young adults study. Biol. Psychiatry 2009, 66:871-878.
5. Curt G. Impact of fatigue on quality of life in oncology patients. Semin. Hematol. 2000, 37:14-17.
6. Danese A., Pariante C.M., Caspi A., Taylor A., Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc. Natl. Acad. Sci. USA 2007, 104:1319-1324.
7. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. 2008, 9:46-56.
8. Eisenberger N.I., Inagaki T.K., Mashal N.M., Irwin M.R. Inflammation and social experience: an inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav. Immun. 2010, 24:558-563.
9. Fagundes C.P., Lindgren M.E., Shapiro C.L., Kiecolt-Glaser J.K. Child maltreatment and breast cancer survivors: social support makes a difference for quality of life, fatigue and cancer stress. Eur. J. Cancer 2011.
10. Friedman G.D., Cutter G.R., Donahue R.P., Hughes G.H., Hulley S.B., Jacobs D.R., Liu K., Savage P.J. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J. Clin. Epidemiol. 1988, 41:1105-1116.
11. Ganz P.A., Kwan L., Stanton A.L., Krupnick J.L., Rowland J.H., Meyerowitz B.E., Bower J.E., Belin T.R. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J. Natl. Cancer Inst. 2004, 96:376-387.
12. Han C., Pulling C.C., Telke S.E., Hullsiek K.H. Assessing the utility of five domains in SF-12 Health Status Questionnaire in an AIDS clinical trial. AIDS 2002, 16:431.
13. Hann D.M., Jacobsen P.B., Azzarello L.M., Martin S.C., Curran S.L., Fields K.K., Greenberg H., Lyman G. Measurement of fatigue in cancer patients: development and validation of the fatigue symptom inventory. Qual. Life Res. 1998, 7:301-310.
14. Heim C., Wagner D., Maloney E., Papanicolaou D.A., Solomon L., Jones J.F., Unger E.R., Reeves W.C. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch. Gen. Psychiatry 2006, 63:1258-1266.
15. Hurst N.P., Ruta D.A., Kind P. Comparison of the MOS short form-12 (SF12) health status questionnaire with the SF36 in patients with rheumatoid arthritis. Rheumatology (Oxford) 1998, 37:862-869.
16. Irwin M.R., Cole S.W. Reciprocal regulation of the neural and innate immune systems. Nat. Rev. Immunol. 2011, 11:625-632.
17. Janicki-Deverts D., Cohen S., Adler N.E., Schwartz J.E., Matthews K.A., Seeman T.E. Socioeconomic status is related to urinary catecholamines in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosom. Med. 2007, 69:514-520.
18. Jenkinson C., Layte R., Jenkinson D., Lawrence K., Petersen S., Paice C., Stradling J. A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies?. J. Public Health 1997, 19:179-186.
19. MacKinnon D.P., Lockwood C.M., Hoffman J.M., West S.G., Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol. Methods 2002, 7:83-104.
20. Marmot M., Brunner E. Cohort profile: the Whitehall II study. Int. J. Epidemiol. 2005, 34:251-256.
21. McCauley J., Kern D.E., Kolodner K., Dill L., Schroeder A.F., DeChant H.K., Ryden J., Derogatis L.R., Bass E.B. Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA 1997, 277:1362-1368.
22. Miller G.E., Chen E., Fok A.K., Walker H., Lim A., Nicholls E.F., Cole S., Kobor M.S. Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc. Natl. Acad. Sci. USA 2009, 106:14716-14721.
23. Myers G.L., Rifai N., Tracy R.P., Roberts W.L., Alexander R.W., Biasucci L.M., Catravas J.D., Cole T.G., Cooper G.R., Khan B.V., Kimberly M.M., Stein E.A., Taubert K.A., Warnick G.R., Waymack P.P. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice. Report from the Laboratory Science Discussion Group. Circulation 2004, 110:e545-549.
24. O'Connor M.F., Bower J.E., Cho H.J., Creswell J.D., Dimitrov S., Hamby M.E., Hoyt M.A., Martin J.L., Robles T.F., Sloan E.K., Thomas K.S., Irwin M.R. To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav. Immun. 2009.
25. Parker E.D., Schmitz K.H., Jacobs D.R., Dengel D.R., Schreiner P.J. Physical activity in young adults and incident hypertension over 15 years of follow-up: the CARDIA study. Am. J. Public Health 2007, 97:703-709.
26. Pawlikowska T., Chalder T., Hirsch S.R., Wallace P., Wright D.J., Wessely S.C. Population based study of fatigue and psychological distress. BMJ 1994, 308:763-766.
27. Powers D.A., Xie Y. Statistical Methods for Categorical Data Analysis 2000, Academic Press, San Diego.
28. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:385.
29. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58:445-452.
30. Ricci J.A., Chee E., Lorandeau A.L., Berger J. Fatigue in the US workforce. Prevalence and implications for lost productive work time. J. Occup. Environ. Med. 2007, 49:1-10.
31. Romans S., Belaise C., Martin J., Morris E., Raffi A. Childhood abuse and later medical disorders in women. An epidemiological study. Psychother. Psychosom. 2002, 71:141-150.
32. Sidney S., Jacobs D.R., Haskell W.L., Armstrong M.A., Dimicco A., Oberman A., Savage P.J., Slattery M.L., Sternfeld B., Van Hom L. Comparison of two methods of assessing physical activity in the coronary artery risk development in young adults (CARDIA) study. Am. J. Epidemiol. 1991, 133:1231-1245.
33. Smets E., Garssen B., Bonke B., De Haes J. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 1995, 39:315-325.
34. Stewart W.F., Ricci J.A., Chee E., Hahn S.R., Morganstein D. Cost of lost productive work time among US workers with depression. JAMA 2003, 289:3135-3144.
35. Stewart W.F., Ricci J.A., Chee E., Morganstein D., Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003, 290:2443-2454.
36. Steyerberg E.W., Eijkemans M.J., Harrell F.E., Habbema J.D. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat. Med. 2000, 19:1059-1079.
37. Taylor S.E., Lehman B.J., Kiefe C.I., Seeman T.E. Relationship of early life stress and psychological functioning to adult C-reactive protein in the coronary artery risk development in young adults study. Biol. Psychiatry 2006, 60:819-824.
38. Valdini A.F. Fatigue of unknown aetiology- a review. Fam. Pract. 1985, 2:48-53.
39. Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med. Care 1996, 34:220-233.